Market Tracker

01/22 3:05pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

46.55
BATS BZX Real-Time Price
As of 3:02pm ET
 -0.35 / -0.75%
Today’s Change
23.40
Today|||52-Week Range
50.05
+16.81%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close46.90
Today’s open47.15
Day’s range45.80 - 48.60
Volume50,176
Average volume (3 months)616,173
Market cap$2.4B
Data as of 3:02pm ET, 01/22/2018

Growth & Valuation

Earnings growth (last year)+528.57%
Earnings growth (this year)-38.47%
Earnings growth (next 5 years)+27.00%
Revenue growth (last year)+48.87%
P/E ratio42.5
Price/Sales6.07
Price/Book12.22

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.04+0.25%
PRTAProthena Corporation...+1.76+4.45%
IRWDIronwood Pharmaceuti...+0.48+3.12%
HZNPHorizon Pharma PLC+0.41+2.69%
Data as of 3:05pm ET, 01/22/2018

Financials

Next reporting dateMarch 14, 2018
EPS forecast (this quarter)$0.28
Annual revenue (last year)$215.0M
Annual profit (last year)$91.2M
Net profit margin42.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
Chief Financial Officer &
Vice President
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts